✦ LIBER ✦
Safety of Palivizumab in Preterm Infants 29 to 32 Weeks' Gestational Age Without Chronic Lung Disease to Prevent Serious Respiratory Syncytial Virus Infection
✍ Scribed by J. R. Groothuis
- Publisher
- Springer
- Year
- 2003
- Tongue
- English
- Weight
- 109 KB
- Volume
- 22
- Category
- Article
- ISSN
- 0934-9723
No coin nor oath required. For personal study only.